Lasa Supergenerics Ltd Board Meeting Scheduled to Review Quarter Ended June 30, 2026 Financial Results
Lasa Supergenerics Ltd has scheduled a meeting of its Board of Directors to review and approve the unaudited financial results for the quarter ended June 30, 2026. The board meeting is set to take place on Friday, August 14, 2026.The primary agenda item for the management team will be the consideration and approval of the Company’s unaudited financial results covering the specified quarter. Additionally, the board will discuss any other matter as permitted by the Chairperson.
In alignment with regulatory standards regarding insider trading, the company confirmed that the trading window will remain closed until 48 hours after the declaration of the Unaudited financial results for the quarter ended June 30, 2026.
LASA Stock Price Movement
As of 12:56 PM, Lasa Supergenerics Limited shares are edging higher in live trading to ₹7.01, gaining 1.15%. The stock is currently seeing activity with a total traded volume of 14,655 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.